Sandoval Carina, Nisson Karly, Fregoso Oliver I
Molecular Biology Institute, University of California, Los Angeles, California, USA.
Department of Microbiology, Immunology, and Molecular Genetics, University of California, Los Angeles, California, USA.
bioRxiv. 2024 Jan 25:2023.05.23.541990. doi: 10.1101/2023.05.23.541990.
Lentiviral accessory genes enhance replication through diverse mechanisms. HIV-1 accessory protein Vpr modulates the host DNA damage response (DDR) at multiple steps through DNA damage, cell cycle arrest, the degradation of host proteins, and both the activation and repression of DDR signaling. Vpr also alters host and viral transcription; however, the connection between Vpr-mediated DDR modulation and transcriptional activation remains unclear. Here, we determined the cellular consequences of Vpr-induced DNA damage using Vpr mutants that allow us to separate the ability of Vpr to induce DNA damage from cell cycle arrest and other DDR phenotypes including host protein degradation and repression of DDR. RNA-sequencing of cells expressing Vpr or Vpr mutants identified that Vpr alters cellular transcription through mechanisms both dependent and independent of cell cycle arrest. In tissue-cultured U2OS cells and primary human monocyte-derived macrophages (MDMs), Vpr-induced DNA damage activates the ATM-NEMO pathway and alters cellular transcription via NF-κB/RelA signaling. HIV-1 infection of primary MDMs validated Vpr-dependent NF-κB transcriptional activation during infection. Both virion delivered and expressed Vpr induced DNA damage and activated ATM-NEMO dependent NF-κB transcription, suggesting that engagement of the DDR and transcriptional reprogramming can occur during early and late stages of viral replication. Together, our data identifies a mechanism by which Vpr activates NF-κB through DNA damage and the ATM-NEMO pathway, which occur independent of cell cycle arrest. We propose this is essential to overcoming restrictive environments, such as in macrophages, to enhance viral transcription and replication.
慢病毒辅助基因通过多种机制增强复制。HIV-1辅助蛋白Vpr通过DNA损伤、细胞周期阻滞、宿主蛋白降解以及DDR信号的激活和抑制等多个步骤调节宿主DNA损伤反应(DDR)。Vpr还会改变宿主和病毒的转录;然而,Vpr介导的DDR调节与转录激活之间的联系仍不清楚。在这里,我们使用Vpr突变体确定了Vpr诱导的DNA损伤的细胞后果,这些突变体使我们能够将Vpr诱导DNA损伤的能力与细胞周期阻滞以及其他DDR表型(包括宿主蛋白降解和DDR抑制)区分开来。对表达Vpr或Vpr突变体的细胞进行RNA测序发现,Vpr通过依赖和不依赖细胞周期阻滞的机制改变细胞转录。在组织培养的U2OS细胞和原代人单核细胞衍生巨噬细胞(MDM)中,Vpr诱导的DNA损伤激活ATM-NEMO途径,并通过NF-κB/RelA信号改变细胞转录。原代MDM的HIV-1感染验证了感染期间Vpr依赖的NF-κB转录激活。病毒体递送和表达的Vpr均诱导DNA损伤并激活ATM-NEMO依赖的NF-κB转录,这表明DDR的参与和转录重编程可发生在病毒复制的早期和晚期。总之,我们的数据确定了一种机制,通过该机制Vpr通过DNA损伤和ATM-NEMO途径激活NF-κB,这一过程独立于细胞周期阻滞发生。我们认为这对于克服限制性环境(如在巨噬细胞中)以增强病毒转录和复制至关重要。